S
Swee Seong Wong
Researcher at Eli Lilly and Company
Publications - 8
Citations - 2537
Swee Seong Wong is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 7, co-authored 8 publications receiving 1920 citations.
Papers
More filters
Journal ArticleDOI
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu,Jeeyun Lee,Michael Nebozhyn,Kyoung-Mee Kim,Jason C. Ting,Swee Seong Wong,Jiangang Liu,Yong Gang Yue,Jian Wang,Kun Yu,Xiang S. Ye,In-Gu Do,Shawn Liu,Lara Gong,Jake Fu,Jason Gang Jin,Min Gew Choi,Tae Sung Sohn,Joon-Ho Lee,Jae Moon Bae,Seung Tae Kim,Se Hoon Park,Insuk Sohn,Sin-Ho Jung,Patrick Tan,Ronghua Chen,James S. Hardwick,Won Ki Kang,Mark Ayers,Dai Hongyue,Christoph Reinhard,Andrey Loboda,Sung Kim,Amit Aggarwal +33 more
TL;DR: This work uses gene expression data to describe four molecular subtypes linked to distinct patterns of molecular alterations, disease progression and prognosis in gastric cancer, and describes key molecular alterations in each of the four subtypes using targeted sequencing and genome-wide copy number microarrays.
Journal ArticleDOI
Cistrome: an integrative platform for transcriptional regulation studies.
Tao Liu,Jorge A Ortiz,Len Taing,Clifford A. Meyer,Bernett Lee,Yong Zhang,Hyunjin Shin,Swee Seong Wong,Jian Ma,Ying Lei,Utz Johann Pape,Michael Poidinger,Yiwen Chen,Kevin Yeung,Myles Brown,Yaron Turpaz,X. Shirley Liu +16 more
TL;DR: A web-based application called Cistrome, based on the Galaxy open source framework, that has 29 ChIP-chip- and Chip-seq-specific tools in three major categories, from preliminary peak calling and correlation analyses to downstream genome feature association, gene expression analyses, and motif discovery.
Journal ArticleDOI
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong,Lacey M. Litchfield,Yue Webster,Li-Chun Chio,Swee Seong Wong,Trent R. Stewart,Michele Dowless,Jack A. Dempsey,Yi Zeng,Raquel Torres,Karsten Boehnke,Cecilia Mur,Carlos Marugán,Carmen Baquero,Chunping Yu,Steven M. Bray,Isabella H. Wulur,Chen Bi,Shaoyou Chu,Hui-Rong Qian,Philip W. Iversen,Farhana F. Merzoug,Xiang S. Ye,Christoph Reinhard,Alfonso De Dios,Jian Du,Charles W. Caldwell,Maria Jose Lallena,Richard P. Beckmann,Sean Buchanan +29 more
TL;DR: A subset of cancers highly sensitive to CDK4/6 inhibition is reported and characterized by various genomic aberrations known to elevate D-cyclin levels and a recurrent CCND1 3'UTR mutation associated with increased expression in endometrial cancer is described.
Journal ArticleDOI
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing.
Swee Seong Wong,Kyoung-Mee Kim,Jason C. Ting,Kun Yu,Jake Fu,Shawn Liu,Razvan Cristescu,Michael Nebozhyn,Lara Gong,Yong Gang Yue,Jian Wang,Chen Ronghua,Andrey Loboda,James S. Hardwick,Xiaoqiao Liu,Hongyue Dai,Jason Gang Jin,Xiang S. Ye,So Young Kang,In Gu Do,Joon Oh Park,Tae Sung Sohn,Christoph Reinhard,Jeeyun Lee,Sung Kim,Amit Aggarwal +25 more
TL;DR: In this paper, the authors performed whole-genome sequencing of 49 GCs with diffuse (N=31) and intestinal (N = 18) histological subtypes and identified three mutational signatures, impacting TpT, CpG and TpCp[A/T] nucleotides.
Journal ArticleDOI
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Shih-Hsun Chen,Youyan Zhang,Robert D. Van Horn,Tinggui Yin,Sean Buchanan,Vipin Yadav,Igor Mochalkin,Swee Seong Wong,Yong Gang Yue,Lysiane Huber,Ilaria Conti,Henry James Robert,James J. Starling,Gregory D. Plowman,Sheng-Bin Peng +14 more
TL;DR: Oncogenic BRAF deletions with a distinct activation mechanism dependent on the BRAF dimer formation in tumor cells are discovered and LY3009120 is active against these cells and represents a potential treatment option for patients with cancer, or other atypical BRAF mutations where BRAF functions as a dimer.